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Preface to the special issue of Food and Chemical Toxicology on the 1 
outcomes of the MARLON project on veterinary epidemiology of 2 
potential health impacts of genetically modified feeds in livestock 3 
Peadar Lawlor (Teagasc, Ireland) 4 
Michelle M. Epstein (Medical University of Vienna, Austria) 5 
Gijs A. Kleter (RIKILT Wageningen University and Research, Netherlands) 6 
 7 
This special issue is a collection of articles dedicated to the impact of genetically 8 
modified (GM) animal feeds on the health of livestock. It features the outcomes 9 
of the research project titled “Monitoring of Animals for Feed-related Risks in the 10 
Long Term (MARLON)”. MARLON was a three-year research project funded by 11 
the European Union’s (EU) Seventh Framework Program for research and 12 
technology development (MARLON, 2015). It focused on monitoring livestock in 13 
commercial production scenarios for potential health impacts associated with 14 
feeds containing GM ingredients. There has been a rapid rate of adoption of GM 15 
feed ingredients especially GM-soybean, maize, oilseed rape and cottonseed in 16 
non-EU countries, since their commercial large-scale introduction in the mid-90s 17 
(James, 2017). They are now common ingredients in livestock feed. In addition 18 
to addressing GM feeds, the methodology and insights gained from the project 19 
can be broadly applied to the surveillance of health effects of livestock feeds and 20 
hazards in general. 21 
 22 
MARLON operated at the interface of science, legislation and policy. It brought 23 
together scientists from 11 European institutions with complementary expertise 24 
including veterinary health and epidemiology, livestock production, biosafety of 25 
GM crops, food and feed safety. MARLON’s activities included stakeholder 26 
consultations, a training course and a final conference. The main outcomes of 27 
MARLON were new knowledge, guidelines and methodologies for monitoring GM 28 
feed ingredient-related health impacts for key stakeholders including European 29 
regulators. MARLON’s progressive approach relates to the possibility that 30 
monitoring of GM feeds and foods may become necessary because they are 31 
regulated and can only be marketed after regulatory approval. In fact, EU 32 
legislation on GM foods and feeds has a provision that a post-market monitoring 33 
may be required based on the outcome of the pre-market risk assessment (EU, 34 
2003). Thus, a key outcome of MARLON was providing European policy makers 35 
with pertinent new knowledge on several safety topics regarding GM crops which 36 
added to the outcomes from other EU projects including GMSAFOOD, GRACE and 37 
G-TwYST projects and the French government-funded GMO90+ projects that 38 
focussed on in vivo and in vitro biomarkers, methods for safety testing of GM 39 
crops and collation of the existing evidence on the potential health, 40 
environmental and economic impacts of GM crops. 41 
 42 
When the MARLON project began, there were a few challenges to address. For 43 
example, a requirement for case-specific monitoring to verify potential risks 44 
identified or assumptions made during the pre-market safety assessment was 45 
only necessary for foods derived from GM oilseed crops with a modified fatty 46 
acid composition, which might have potential to impact human nutrition and 47 
health. In addition, there was a requirement for general, passive surveillance of 48 
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animal health impacts as part of the general surveillance carried out for all GM 49 
crops that had received approval for “environmental release” (e.g., field 50 
cultivation, import and processing of seeds and other viable GM crop products) 51 
(EU, 2001). Therefore, MARLON activities had to be anticipatory because it was 52 
not possible to rely on past case-specific monitoring experience. This was 53 
especially challenging because negative health effects due to approved GM 54 
products were not known to exist. Another challenge was that the approach to 55 
developing monitoring methods should be universally applicable because it was 56 
not possible to foresee for which combination of GM feed, livestock species and 57 
health parameters monitoring could be required. Additionally, it was necessary 58 
to use data from existing animal health surveillance activities, which were either 59 
generic or focused on the impact of non-feed-related animal health. 60 
 61 
This special issue addresses the following questions: 62 
• Are there known health impacts related to GM-crop-derived livestock feeds? 63 
(De Vos and Swanenburg, 2018)  64 
• Would it be possible to measure the exposure of animals to specific GM feed 65 
ingredients? (Nadal et al., 2018) 66 
• Can health indicators be specified by regulators for the monitoring of 67 
livestock for possible health effects of GM feeds? (De Santis et al., 2018) 68 
• How are different feed and livestock production chains organized and 69 
characterised (e.g., husbandry practices, regulations, traceability, and health 70 
checks)? (Kleter et al., 2018) 71 
• Is it possible to design monitoring programs to exploit data from existing 72 
surveillance for the detection of unusual trends in animal health parameters 73 
which is collated in IPAFEED and relate this to the consumption of GM feeds? 74 
(Vince et al., 2018) 75 
 76 
De Vos and Swanenburg (De Vos and Swanenburg, 2018) in their review of the 77 
literature addressed whether there are there known health impacts related to 78 
GM-crop-derived livestock feeds. They focussed on controlled livestock feeding 79 
studies with the aim to collate state-of-the-art knowledge on health parameter 80 
(e.g., serum chemistry, pathology, etc.) perturbations associated with feeding of 81 
GM ingredients. They explored relevant previously reported health parameter 82 
changes and provided a systematic annotation of all health parameters 83 
measured in a newly established database called IPAFEED (IPAFEED, 2015; 84 
Vince et al., 2018), which is available to regulators to assess the design of 85 
monitoring schemes based on previously reported health parameters. Notably, 86 
there were no adverse effects linked to GM feeds on any health parameters. 87 
 88 
The review by Nadal and co-workers (Nadal et al., 2018) focussed on whether it 89 
would be possible to measure the exposure of animals to specific GM feed 90 
ingredients with the notion that it might link exposure to ingredients with 91 
adverse health effects in an individual or cohort of animals. They also addressed 92 
whether ingredients could be traced and detected throughout the feed and 93 
livestock production chains, and whether there are markers for exposure in 94 
livestock animals, (e.g., via uptake of GM material from feed into tissues, fluids, 95 
and excreta). The review concludes that although it is possible to measure the 96 
presence of specific ingredients in feeds based on GM-crop-related proteins or 97 
DNA, there are no markers for animal exposure. Therefore, traceability 98 
measures have not yet traced and quantified an animal’s exposure to a specific 99 
GM feed ingredient. 100 
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 101 
De Santis and co-workers addressed whether health indicators can be specified 102 
by regulators for the monitoring of livestock for possible health effects of GM 103 
feeds in their review (De Santis et al., 2018). They explored four scenarios: 1) 104 
potential allergic reactions induced by GM feeds as compared to non-GM feeds in 105 
livestock animals; 2) horizontal gene transfer from consumed GM crops to 106 
intestinal microorganisms and the host animal; 3) reduced incidence of 107 
mycotoxins in GM feeds; and 4) nutritionally altered GM crops. The authors 108 
concluded that there were no adverse effects to GM feeding in the literature for 109 
these scenarios. There is evidence, however, of beneficial effects related to a 110 
reduction of the mycotoxin fumonisin in insect-resistant GM crop varieties and 111 
through nutritional enhancement of crops. 112 
 113 
The Kleter and co-workers’ (Kleter et al., 2018) review approached the 114 
organization and characterization of different feed and livestock production 115 
chains (e.g., husbandry practices, regulations, traceability, and health checks) 116 
with the aim to determine how the movement of feeds and animals through the 117 
production chain are recorded and how this could be used for monitoring of 118 
animal health effects. The authors concluded that for livestock, traceability at 119 
herd or individual levels are possible depending on the livestock species. 120 
Although the existing animal traceability systems are designed for infectious 121 
disease reporting or animal identification, it is not possible to trace GM 122 
ingredients (even if it is labelled correctly) back to the farms of origin or to verify 123 
the distribution and inclusion level in the feeds. 124 
 125 
The last review by Vince and co-workers addresses designing monitoring 126 
programs to exploit data from existing surveillance for the detection of unusual 127 
trends in animal health parameters, which is collated in IPAFEED, and relate this 128 
to the consumption of GM feeds. The review reveals a broad methodology to 129 
assist the monitoring of GM feed-related health effects (Vince et al., 2018). This 130 
was a key challenge for MARLON because there were no recorded GM feed-131 
related health effects and no methods for quantifying prior exposure of the 132 
animals to GM feed. The authors reviewed various types of existing veterinary 133 
surveillance, which aim at providing evidence for freedom from specific diseases, 134 
early detection of outbreaks, and monitoring of endemic diseases including 135 
syndromic surveillance (e.g., non-specific health parameters), risk-based 136 
surveillance, collection-point-based surveillance, checkpoint surveillance, 137 
sentinel herd surveillance and representative surveys. In addition, they reported 138 
on a probabilistic approach towards syndromic surveillance that estimates the 139 
likelihood that an effect will be detected above background variability through 140 
existing reporting systems. Importantly, this approach considers the production 141 
chain, from farmer via veterinarian and clinical laboratory, to post-mortem 142 
abattoir inspection. The authors concluded that observed effects or deviating 143 
trends would need follow-up with confirmatory research under controlled 144 
conditions and suggested that managers should consider cost-effectiveness 145 
compared with alternative options when setting up a surveillance scheme. 146 
 147 
In summary, the reviews in this section provide comprehensive overviews of 148 
published controlled feeding livestock studies with GM crops checking for health 149 
impacts beyond solely performance, the possibilities to detect GM feed 150 
ingredients and the animals’ exposure to them, the possibility to employ health 151 
indicators for four hypothetical scenarios including allergenicity, horizontal gene 152 
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transfer, changed mycotoxin levels, and nutritional improvement, the 153 
organization of feed and livestock production chains in Europe, and the 154 
possibilities for applying veterinary epidemiology to surveillance of possible GM 155 
feed-related health impacts. The generic, statistical approach developed within 156 
MARLON will assist in the design of monitoring programs based on syndromic 157 
surveillance for GM and non-GM feeds which would then rely on existing data of 158 
health syndromes commonly measured in livestock production. This also concurs 159 
with recent trends in syndromic surveillance, mining of big data and domestic 160 
animal toxicology.  161 
 162 
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